$AMBQ

Esaka Fumihide sold $1.2M of AMBQ

Esaka Fumihide (Chief Executive Officer) sold 16,560 shares of Ambiq Micro, Inc. (AMBQ) at an average of $69.60 ($69.11–$71.86, $1.15M total) across 3 trades on 2026-10-02.

Original reporting
SEC EDGAR · Esaka Fumihide
Published Oct 6, 2026, 10:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 10:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

The disclosed sale may prompt short sellers and cause a modest dip in AMBQ's price.

02

Market read

Insider sell by the CEO is a notable event for a micro‑cap, offering limited but actionable insight for short‑term traders.

03

What to watch

Potential tax planning or diversification needs of the executive.

Relevance 6/10Novelty 5/10Timing: today

Background

Form 4 filings disclose insider transactions and are primary sources for insider activity.

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

CEO Esaka Fumihide sold 16,560 shares for $1.15M in a Form 4 filing on 2026-10-02.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

A $1.15M sale by the chief executive is material for a micro‑cap and often triggers short‑term downside bias.

Market effects

Minimal impact on the broader semiconductor sector.

Limited to U.S. investors tracking micro‑cap biotech/semiconductor stocks.

Low

Counterpoint

The sale could be a routine liquidity move unrelated to company outlook.

Key entities

  • Esaka Fumihide

    Chief Executive Officer of Ambiq Micro, Inc.

  • Ambiq Micro, Inc.

    Micro‑cap semiconductor company listed on Nasdaq under AMBQ.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMBQMed

Jefferies initiates Ambiq Micro stock with buy rating on AI edge computing potential

Jefferies initiated coverage on Ambiq Micro (NYSE: AMBQ) with a buy rating and $90 price target, citing its AI edge computing potential. The company's SPOT architecture offers power advantages for edge devices. Ambiq Micro reported 89.7% revenue growth in Q2, with full-year sales outlook raised to $135 million. Several analysts revised earnings upwards, and multiple firms increased price targets.

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

$AMBQHigh

Ambiq Reports Second Quarter 2026 Financial Results

Ambiq Micro, Inc. (AMBQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ambiq Reports Second Quarter 2026 Financial Results Delivered record quarterly net sales, increasing approximately 90% year-over-year, driven by strong demand for edge AI solutions Gross profit more than doubled year-over-year on higher net sales and margin expansion Expect third